Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
137 pending office actions • 42 art units • 113 examiners • 0 of 137 (0%) have an AI response strategy ready • 132 patents granted in the last 365 days
Amgen Inc. maintains a portfolio with 132 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are spread across 41 distinct art units, reflecting the range of research and development. The company interacts with 110 distinct examiners, indicating diversity in the individuals reviewing their patent applications.
ZACHARY S SKELDING is the busiest examiner for the portfolio, currently handling 4 pending office actions. While this is the count for this individual, it represents a fraction of the 132 pending office actions total. The reliance on 110 distinct examiners suggests that prosecution strategies must be adapted to a variety of examiner preferences and styles.
The distribution across 41 distinct art units highlights the structure of this portfolio within the Biotechnology & Pharmaceuticals sector. Given the total volume of matters, the workload is distributed, yet the busiest examiner only manages 4 of these actions. This structure requires a decentralized approach to prosecution management across the 110 distinct examiners involved.
Based on the USPTO statutory response window for each pending office action. 38 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 38 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (1%) |
| §101 + other | 11 (8%) |
| §103 only | 29 (21%) |
| §102 only | 5 (4%) |
| §112 only | 10 (7%) |
| Double-patenting only | 4 (3%) |
| Double-patenting + other | 24 (18%) |
| Multi-statute (no §101) | 51 (37%) |
| No statute on record | 2 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SKELDING, ZACHARY S | 4 | 59.7% | +41.2% |
| BRISTOL, LYNN ANNE | 3 | 63.4% | +39.8% |
| DUFFY, BRADLEY | 3 | 54.5% | +45.8% |
| WITTLIFF, KATERINA ANNA | 3 | 35.0% | +18.8% |
| TECCO, ANDREW M | 2 | 65.4% | +24.7% |
| BOUCHELLE, LAURA A | 2 | 80.2% | +10.7% |
| PATEL, SHEFALI DILIP | 2 | 58.0% | +27.7% |
| HALL, DEANNA K | 2 | 75.7% | +15.7% |
| BANERJEE, KOYELI | 2 | 50.0% | +0.0% |
| FREHE, WILLIAM R | 2 | 59.9% | +42.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17846310 | SYRINGES, ASSEMBLIES, AND METHODS OF MANUFACTURE | BOUCHELLE, LAURA A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18018389 | CELL CULTURE MEDIA AND METHODS OF MAKING AND USING THE SAME | VAN BUREN, LAUREN K | 153d overdue |
| 17775386 | Method for Reduced Aggregate Formation in Downstream Processing of Bispecific Antigen-Binding Molecules | SKELDING, ZACHARY S | 52d overdue |
| 18270581 | USE OF KRAS G12C INHIBITOR IN TREATING CANCERS | HASTINGS, ALISON AZAR | 23d overdue |
| 18562107 | SOTORASIB DOSING REGIMEN | CHANDRAKUMAR, NIZAL S | 18d overdue |
| 17773892 | HIGH SALT WASHES DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES | SHELTON, SYNPHANE LA'SHAWN | 1d overdue |
| 17436218 | IN VIVO REVERSIBILITY OF HIGH MOLECULAR WEIGHT SPECIES | FRITCHMAN, REBECCA M | 8d |
| 18266689 | DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES | SPENCE, JENNIFER SUZANNE | 12d |
| 18038579 | ENANTIOSELECTIVE ALKENYLATION OF ALDEHYDES | MOORE, SUSANNA | 16d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18042267 | ANTIGEN BINDING PROTEINS WITH NON-CANONICAL DISULFIDE IN FAB REGION | BRISTOL, LYNN ANNE | 93d overdue |
| 16586318 | CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS | SKELDING, ZACHARY S | 77d overdue |
| 17775386 | Method for Reduced Aggregate Formation in Downstream Processing of Bispecific Antigen-Binding Molecules | SKELDING, ZACHARY S | 52d overdue |
| 17775063 | ENGINEERING CHARGE PAIR MUTATIONS FOR PAIRING OF HETERO-IgG MOLECULES | DUFFY, BRADLEY | 45d overdue |
| 17770349 | DRUG DELIVERY SYSTEM AND METHOD OF USE | WITTLIFF, KATERINA ANNA | 27d |
| 18962768 | AUTOMATED SYSTEMS AND METHODS FOR FOIL PACKAGING COMPONENTS | TECCO, ANDREW M | — |
| 18845286 | PACKAGING FOR DRUG DELIVERY DEVICE | TECCO, ANDREW M | — |
| 18789085 | DRUG DELIVERY DEVICE | BOUCHELLE, LAURA A | — |
| Art Unit | Apps |
|---|---|
| 3783 | 30 |
| 1641 | 8 |
| 1643 | 8 |
| 1674 | 6 |
| 1644 | 6 |
| 3731 | 3 |
| 1633 | 3 |
| 1652 | 3 |
| 1658 | 3 |
| 1647 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19045308 | ROBOTIC SYSTEM FOR PERFORMING PATTERN RECOGNITION-BASED INSPECTION OF PHARMACEUTICAL CONTAINERS | RODRIGUEZ, JOSEPH C | 3653 | §103Other | Non-Final OA | — | Pending | Feb 04, 2025 |
| 18878828 | ANTI-PD-1 ANTIBODY FORMULATIONS | OGUNBIYI, OLUWATOSIN A | — | §103§112 | Non-Final OA | — | Pending | Dec 24, 2024 |
| 18962768 | AUTOMATED SYSTEMS AND METHODS FOR FOIL PACKAGING COMPONENTS | TECCO, ANDREW M | 3731 | §102§103 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18939822 | PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR | O DELL, DAVID K | — | DP | Non-Final OA | — | Pending | Nov 07, 2024 |
| 18934755 | SUSTAINABLE AND MODULAR PACKAGING SYSTEMS FOR CONTAINERS FOR PHARMACEUTICAL USE | ORTIZ, RAFAEL ALFREDO | 3736 | §103§112 | Non-Final OA | — | Pending | Nov 01, 2024 |
| 18855457 | COMPLEMENT-DEPENDENT CYTOTOXICITY METHODS | CURRENS, GRANT CARSON | — | §103 | Non-Final OA | — | Pending | Oct 09, 2024 |
| 18853977 | SYSTEMS AND METHODS FOR REDUCING EXCESS RESOURCE USAGE | KESSLER, GREGORY AARON | — | §101§102 | Non-Final OA | — | Pending | Oct 03, 2024 |
| 18853736 | Cancer Treatments Using MTA-Cooperative PRMT5 Inhibitors | MCKOY, QUINCY ANDRE | — | §103§112DP | Non-Final OA | — | Pending | Oct 03, 2024 |
| 18845286 | PACKAGING FOR DRUG DELIVERY DEVICE | TECCO, ANDREW M | 3731 | §102§103§112 | Non-Final OA | — | Pending | Sep 09, 2024 |
| 18807705 | MACHINE LEARNING (ML)-BASED SYSTEMS AND METHODS FOR PREDICTING DISEASE | EVANS, ASHLEY ELIZABETH | 3687 | §101§103 | Non-Final OA | 39d | Pending | Aug 16, 2024 |
| 18798878 | AFLIBERCEPT ATTRIBUTES AND METHODS OF CHARACTERIZING AND MODIFYING THEREOF | BORGEEST, CHRISTINA M | — | §101§102§103§112 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18789085 | DRUG DELIVERY DEVICE | BOUCHELLE, LAURA A | — | §102§103Other | Non-Final OA | — | Pending | Jul 30, 2024 |
| 18832887 | SYNTHESIS OF A KIF18A INHIBITOR | OH, TAYLOR V | — | §102§112 | Non-Final OA | — | Pending | Jul 24, 2024 |
| 18730357 | Crystalline Forms Of An MCL-1 Inhibitor | SAMSELL, RILLA MARIE | — | §102§103§112 | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18770259 | ASGR INHIBITORS | HOWARD, ZACHARY C | 1674 | §102§103§112 | Non-Final OA | — | Pending | Jul 11, 2024 |
| 18744036 | AUTOINJECTOR WITH SHOCK REDUCING ELEMENTS | MEDWAY, SCOTT J | — | §102§103 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18719164 | METHODS FOR DESIGNING AND PERFORMING A VAPOR PHASE HYDROGEN PEROXIDE DECONTAMINATION CYCLE | HOERNER, PAUL ELLSWORTH | 1611 | §112 | Final Rejection | — | Pending | Jun 12, 2024 |
| 18674549 | INJECTION DEVICE FOR DRUG DELIVERY AND PACKAGING FOR THE INJECTION DEVICE | PATEL, SHEFALI DILIP | 3783 | §102§103 | Final Rejection | — | Pending | May 24, 2024 |
| 18710112 | PLUNGER ROD REMOVAL FORCE METHOD AND FIXTURE | PATEL, SHEFALI DILIP | — | §102§103§112 | Non-Final OA | — | Pending | May 14, 2024 |
| 18645779 | CONTROLLABLE DRUG DELIVERY SYSTEM AND METHOD OF USE | HALL, DEANNA K | 3783 | §102§103 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18701723 | COMPOSITION AND METHODS FOR RECOMBINANT LENTIVIRAL PRODUCTION | PRONZATI, GINA | 1633 | §103§112 | Non-Final OA | — | Pending | Apr 16, 2024 |
| 18698098 | FC-GAMMA RECEPTOR II BINDING AND GLYCAN CONTENT | EVANS, CHRISTOPHER RYAN | — | §102§103§112 | Non-Final OA | — | Pending | Apr 03, 2024 |
| 18697770 | CHARACTERIZATION APPARATUS FOR DRUG DELIVERY DEVICES OR SUBCOMPONENTS THEREOF | NATH, SUMAN KUMAR | 2855 | §101 | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18696946 | Heterocyclic Compounds and Methods of Use | CHAO, ALLEN | 1622 | §103DP | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18696167 | IMPACT ACTIVATED RETENTION FEATURE FOR DRUG DELIVERY DEVICE | KASHYAP, ESHA PRAKASH | — | §102§103 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18611364 | ST2 ANTIGEN BINDING PROTEINS | MCCOLLUM, ANDREA K | — | §101§112Other | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18685037 | MYOPEPTIDES AND METHODS OF USE IN TREATING HEART FAILURE | CHERNYSHEV, OLGA N | — | §112 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18684262 | METHODS COMPRISING THERAPEUTIC COMPOUNDS AND IN VITRO MAMMALIAN SKIN | CLARKE, TRENT R | 1651 | §101§103§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18442665 | METHOD FOR PURIFYING PROTEINS | LOUNTOS, GEORGE THEMISTOCLIS | 1652 | §103§112DP | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18435746 | TIGIT AND CD112R BLOCKADE | GAO, ASHLEY HARTMAN | 1678 | §112 | Non-Final OA | — | Pending | Feb 07, 2024 |
| 18291294 | STEREOSELECTIVE PREPARATION OF TRANS HALO CYCLOBUTANE | BAKSHI, PANCHAM | — | §112 | Final Rejection | — | Pending | Jan 23, 2024 |
| 18574161 | METHOD OF RECONSTITUTING LYOPHILIZED FORMULATION | BANERJEE, KOYELI | 1658 | §103 | Non-Final OA | — | Pending | Dec 26, 2023 |
| 18538279 | ANTIBODY CONSTRUCTS FOR MSLN AND CD3 | BRISTOL, LYNN ANNE | — | §112DP | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18562107 | SOTORASIB DOSING REGIMEN | CHANDRAKUMAR, NIZAL S | 1625 | §101§103Other | Non-Final OA | 18d overdue | Pending | Nov 17, 2023 |
| 18561341 | FEEDBACK SYSTEM AND METHOD FOR A DRUG PRODUCT | CASILLASHERNANDEZ, OMAR | 2689 | §103 | Final Rejection | — | Pending | Nov 16, 2023 |
| 18558827 | SOTORASIB FORMULATION | GOTFREDSON, GAREN | 1619 | §103 | Final Rejection | — | Pending | Nov 03, 2023 |
| 18289317 | DOSING REGIMEN FOR COMBINATION THERAPY TARGETING DLL3 AND PD-1 | DUTT, ADITI | 1675 | DP | Non-Final OA | — | Pending | Nov 02, 2023 |
| 18288410 | ETELCALCETIDE FORMULATIONS | LEE, JIA-HAI | 1658 | §103§112DP | Non-Final OA | — | Pending | Oct 26, 2023 |
| 18288549 | METHOD OF OPTIMIZING A FILLING RECIPE FOR A DRUG CONTAINER | SEIF, DARIUSH | 3731 | §102§103§112 | Non-Final OA | 29d | Pending | Oct 26, 2023 |
| 18287593 | ANTI-TSLP ANTIBODY COMPOSITIONS AND USES THEREOF | MIDDLETON, DANAYA L | 1674 | §103§112DP | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18286242 | SYSTEMS AND METHODS TO EVALUATE INACTIVATION KINETICS OF A BIOLOGICAL INDICATOR | NEGIN, RUSSELL SCOTT | — | §101§103 | Non-Final OA | — | Pending | Oct 10, 2023 |
| 18285125 | MAGEB2 BINDING CONSTRUCTS | JOHANSEN, PETER N. | 1644 | §112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18550645 | COMPONENT MATCHING DECISION SUPPORT TOOL | CARTER, CHRISTOPHER W | 2117 | §102 | Final Rejection | — | Pending | Sep 14, 2023 |
| 18550650 | SOUND-DETECTION BASED INJECTION TIME MEASUREMENT SYSTEM FOR DRUG DELIVERY DEVICES | FREHE, WILLIAM R | 3783 | §102§103 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18550647 | DRUG DELIVERY DEVICE | FREHE, WILLIAM R | 3783 | §102§103 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18242116 | LARGE SCALE BIOREACTOR SYSTEM AND METHOD | BRIDGES, DONAVAN LEE | 1758 | §103§112 | Non-Final OA | — | Pending | Sep 05, 2023 |
| 18275855 | NON-TERMINAL ANTIBODY DISCOVERY METHODS AND SINGLE CELL ASSAYS | CHANDRA, GYAN | 1674 | §103§112 | Non-Final OA | — | Pending | Aug 04, 2023 |
| 18270581 | USE OF KRAS G12C INHIBITOR IN TREATING CANCERS | HASTINGS, ALISON AZAR | 1627 | §102§103Other | Final Rejection | 23d overdue | Pending | Jun 30, 2023 |
| 18266689 | DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES | SPENCE, JENNIFER SUZANNE | 1633 | §103§112 | Final Rejection | 12d | Pending | Jun 12, 2023 |
| 18038579 | ENANTIOSELECTIVE ALKENYLATION OF ALDEHYDES | MOORE, SUSANNA | 1624 | §103§112 | Final Rejection | 16d | Pending | May 24, 2023 |
| 18038041 | COMPUTER SURROGATE MODEL TO PREDICT THE SINGLE-PHASE MIXING QUALITY IN STEADY STATE MIXING TANKS | RUTTEN, JAMES D | 2121 | §103 | Non-Final OA | 23d overdue | Pending | May 22, 2023 |
| 18037128 | REAL TIME PCR METHOD TO DETECT BOVINE PARVOVIRUS 3 | SIFFORD, JEFFREY MARK | 1671 | §103§112 | Non-Final OA | — | Pending | May 16, 2023 |
| 18316739 | Antibody Constructs for CLDN18.2 and CD3 | MOSELEY II, NELSON B | 1642 | §112 | Final Rejection | 8d overdue | Pending | May 12, 2023 |
| 18195155 | MACHINE LEARNING TECHNIQUES FOR PREDICTING THERMOSTABILITY | SABOUR, GHAZAL | — | §101§103 | Non-Final OA | — | Pending | May 09, 2023 |
| 18251553 | MATERIALS AND METHODS FOR PROTEIN PROCESSING | BANERJEE, KOYELI | 1658 | §103DP | Final Rejection | 13d | Pending | May 03, 2023 |
| 18035054 | METHODS FOR ADMINISTERING A BCMAXCD3 BINDING MOLECULE | HADDAD, MAHER M | 1641 | §103DP | Final Rejection | 7d | Pending | May 02, 2023 |
| 18032765 | DRUG DELIVERY DEVICE ASSEMBLY AND ACCESSORY FOR DRUG DELIVERY DEVICE | RADOMSKI, MARTIN ADAM | 3783 | §102§103 | Non-Final OA | — | Pending | Apr 19, 2023 |
| 18031691 | RELATIVE UNPAIRED GLYCANS IN ANTIBODY PRODUCTION METHODS | ROBINSON, HOPE A | 1652 | §103§112DP | Final Rejection | — | Pending | Apr 13, 2023 |
| 18248345 | RATIONAL SELECTION OF BUILDING BLOCKS FOR THE ASSEMBLY OF MULTISPECIFIC ANTIBODIES | HUYNH, PHUONG N | 1641 | §103§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18296211 | AMORPHOUS AND CRYSTALLINE FORMS OF MCL-1 ANTAGONISTS | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §102§112Other | Non-Final OA | — | Pending | Apr 05, 2023 |
| 18026678 | METHODS OF PROCESSING A SAMPLE FOR PEPTIDE MAPPING ANALYSIS | ARMATO JR, DENNIS IGNATIUS | 1651 | §103§112 | Non-Final OA | 33d | Pending | Mar 16, 2023 |
| 18025311 | Predicting Shelf Life Stability of Lyophilized Drug Products | TAMIRU, ABRHAM ALEHEGN | 2188 | §101§103 | Non-Final OA | — | Pending | Mar 08, 2023 |
| 18044158 | MATERIALS AND METHODS TO REDUCE PROTEIN AGGREGATION | ALLEN, MARIANNE P | 1647 | §103 | Non-Final OA | — | Pending | Mar 06, 2023 |
| 18022685 | PHARMACEUTICAL FORMULATION | HUYNH, PHUONG N | 1641 | §103§112 | Non-Final OA | — | Pending | Feb 22, 2023 |
| 18042267 | ANTIGEN BINDING PROTEINS WITH NON-CANONICAL DISULFIDE IN FAB REGION | BRISTOL, LYNN ANNE | 1643 | §112 | Final Rejection | 93d overdue | Pending | Feb 20, 2023 |
| 18018389 | CELL CULTURE MEDIA AND METHODS OF MAKING AND USING THE SAME | VAN BUREN, LAUREN K | 1638 | §103§112 | Final Rejection | 153d overdue | Pending | Jan 27, 2023 |
| 18097725 | SYSTEMS AND METHODS FOR DELAYED DRUG DELIVERY | ZAMORY, JUSTIN L | 3783 | §103 | Final Rejection | 44d overdue | Pending | Jan 17, 2023 |
| 18068922 | MAMMALIAN CELL CULTURE | POPA, ILEANA | 1633 | Other | Non-Final OA | — | Pending | Dec 20, 2022 |
| 18002303 | METHODS OF MEASURING CARFILZOMIB | XU, XIAOYUN | 1797 | §103 | Non-Final OA | — | Pending | Dec 19, 2022 |
| 18009682 | CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS | RODRIGUEZ, RAYNA B | 1628 | §103Other | Final Rejection | — | Pending | Dec 09, 2022 |
| 18007560 | RNAI CONSTRUCTS FOR INHIBITING HSD17B13 EXPRESSION AND METHODS OF USE THEREOF | SHIN, DANA H | 1635 | §103§112 | Final Rejection | — | Pending | Dec 01, 2022 |
| 17928561 | ANTIBODY FORMULATIONS AND USES THEREOF | KIM, YUNSOO | 1641 | §103DP | Final Rejection | 85d overdue | Pending | Nov 29, 2022 |
| 17923347 | Deep Learning Platforms for Automated Visual Inspection | HICKS, AUSTIN JAMES | 2142 | §102§103 | Final Rejection | 22d | Pending | Nov 04, 2022 |
| 17921793 | PHARMACEUTICAL FORMULATION | KAUFMAN, CLAIRE M | 1674 | §102§112DP | Final Rejection | 17d overdue | Pending | Oct 27, 2022 |
| 17921794 | PHARMACEUTICAL FORMULATION | SKELDING, ZACHARY S | 1644 | §102§103Other | Final Rejection | — | Pending | Oct 27, 2022 |
| 17916843 | Synthesis of vinylic alcohol intermediates | HAVLIN, ROBERT H | 1626 | §103Other | Final Rejection | 15d overdue | Pending | Oct 04, 2022 |
| 17911510 | CONTROLLED DISPENSE SYRINGE | GRAY, PHILLIP A | 3783 | §102 | Final Rejection | — | Pending | Sep 14, 2022 |
| 17930810 | ADAPTATION OF PLATFORM HOSTS TO IGF- MEDIA | MOORE, JOHN DAVID | 1638 | §103 | Non-Final OA | — | Pending | Sep 09, 2022 |
| 17821835 | Method of Antigen-Binding Protein Production | MARCSISIN, ELLEN JEAN | 1677 | §103Other | Non-Final OA | 182d overdue | Pending | Aug 24, 2022 |
| 17810142 | STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION | BASQUILL, SEAN M | 1614 | §103 | Final Rejection | — | Pending | Jun 30, 2022 |
| 17846310 | SYRINGES, ASSEMBLIES, AND METHODS OF MANUFACTURE | BOUCHELLE, LAURA A | 3783 | §103 | Non-Final OA | — | Pending | Jun 22, 2022 |
| 17834518 | METHODS OF PROTEIN CLIPS RECOVERY | CHIN, CHRISTOPHER L | 1677 | §112DP | Non-Final OA | — | Pending | Jun 07, 2022 |
| 17780596 | FLOW RESTRICTOR FOR DRUG DELIVERY DEVICE | THOMAN, EVELYN ANNE | 3783 | §103§112 | Final Rejection | — | Pending | May 27, 2022 |
| 17778361 | NOVEL MULTISPECIFIC ANTIBODY FORMAT | DONOGHUE, BRITTNEY ERIN | 1675 | §103 | Final Rejection | 19d overdue | Pending | May 19, 2022 |
| 17775386 | Method for Reduced Aggregate Formation in Downstream Processing of Bispecific Antigen-Binding Molecules | SKELDING, ZACHARY S | 1644 | §103§112 | Final Rejection | 52d overdue | Pending | May 09, 2022 |
| 17775063 | ENGINEERING CHARGE PAIR MUTATIONS FOR PAIRING OF HETERO-IgG MOLECULES | DUFFY, BRADLEY | 1643 | §102 | Final Rejection | 45d overdue | Pending | May 06, 2022 |
| 17775257 | METHOD OF TREATING OR AMELIORATING CUSHING'S SYNDROME USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) | ALLEN, MARIANNE P | 1647 | §103DP | Final Rejection | 87d overdue | Pending | May 06, 2022 |
| 17774232 | MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES | KAUFMAN, CLAIRE M | 1674 | §102§103§112 | Non-Final OA | — | Pending | May 04, 2022 |
| 17773892 | HIGH SALT WASHES DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES | SHELTON, SYNPHANE LA'SHAWN | 1652 | §102§103 | Final Rejection | 1d overdue | Pending | May 03, 2022 |
| 17773886 | HIGH SALT LOAD CONDITIONING DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES | DEBERRY, REGINA M | 1647 | DP | Final Rejection | 88d overdue | Pending | May 03, 2022 |
| 17771313 | COMPOSITIONS AND METHODS FOR MINIMIZING PROTEIN LOSS AT LOW PROTEIN CONCENTRATIONS | XIE, XIAOZHEN | 1674 | §103 | Non-Final OA | 5d | Pending | Apr 22, 2022 |
| 17770349 | DRUG DELIVERY SYSTEM AND METHOD OF USE | WITTLIFF, KATERINA ANNA | 3783 | §103 | Final Rejection | 27d | Pending | Apr 20, 2022 |
| 17770341 | DRUG DELIVERY DEVICE AND SYSTEM | WITTLIFF, KATERINA ANNA | 3783 | §102§103§112 | Non-Final OA | — | Pending | Apr 20, 2022 |
| 17767462 | CASSETTE FOR AN AUTOINJECTOR AND RELATED METHODS | VOKES, KATHLEEN PAIGE | 3783 | §102§103§112 | Non-Final OA | — | Pending | Apr 08, 2022 |
| 17767469 | DRUG DELIVERY DEVICE AND SYSTEM | WITTLIFF, KATERINA ANNA | 3783 | §103 | Final Rejection | — | Pending | Apr 08, 2022 |
| 17767471 | DRUG DELIVERY DEVICE AND SYSTEM | KOO, BENJAMIN K | 3783 | §103 | Final Rejection | — | Pending | Apr 08, 2022 |
| 17767111 | DRUG DELIVERY DEVICE | TAYLOR, MARISSA ENVENESIA | 3783 | §102§103§112 | Non-Final OA | — | Pending | Apr 07, 2022 |
| 17763692 | DRUG PRODUCT CONTAINER AND DRUG DELIVERY SYSTEM | PAZ ESTEVEZ, GUILLERMO G | 3783 | §103 | Final Rejection | — | Pending | Mar 25, 2022 |
| 17702131 | V-C-FC-V-C ANTIBODY | SHUPE, ELIZABETH A | 1643 | §103§112 | Final Rejection | — | Pending | Mar 23, 2022 |
| 17697632 | BISPECIFIC FC MOLECULES | FAUST, AMBER KATHLEEN | 1643 | §103 | Final Rejection | — | Pending | Mar 17, 2022 |
| 17637520 | ACTIVATABLE INJECTION DEVICE FOR DRUG DELIVERY | DANIEL, ANTARIUS S | 3783 | §102 | Non-Final OA | — | Pending | Feb 23, 2022 |
| 17630207 | DRUG DELIVERY DEVICE WITH TEMPERATURE MEASUREMENT AND RELATED METHOD | HALL, DEANNA K | 3783 | §102 | Non-Final OA | — | Pending | Jan 26, 2022 |
| 17630270 | DRUG DELIVERY DEVICE WITH CONFIGURABLE NEEDLE SHIELD ENGAGEMENT COMPONENTS AND RELATED METHODS | MARRISON, SAMUEL JOSEPH | 3783 | §103 | Non-Final OA | 26d | Pending | Jan 26, 2022 |
| 17621135 | Wireless Communication Enabled Drug Delivery Device and Method | PAZ ESTEVEZ, GUILLERMO G | 3783 | §102§103 | Non-Final OA | — | Pending | Dec 20, 2021 |
| 17616580 | BISPECIFIC BINDING CONSTRUCTS | MELCHIOR, JAMES RYLAND | 1644 | §103DP | Final Rejection | — | Pending | Dec 03, 2021 |
| 17615520 | RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF | SULLIVAN, STEPHANIE LAUREN | 1635 | §103DP | Final Rejection | 1d overdue | Pending | Nov 30, 2021 |
| 17537922 | AUTOINJECTOR WITH STALL AND END POINT DETECTION | ALLEN, ROBERT F | 3783 | §103 | Non-Final OA | — | Pending | Nov 30, 2021 |
| 17514763 | PLUNGERS FOR DRUG DELIVERY DEVICES | RITCHIE, HADEN MATTHEW | 3783 | §103 | Final Rejection | — | Pending | Oct 29, 2021 |
| 17602148 | DRUG DELIVERY DEVICE WITH SMART GRIP | DIOP, FATIMATA SAHRA | 3783 | §102§103 | Non-Final OA | — | Pending | Oct 07, 2021 |
| 17599028 | USE OF ONCOLYTIC VIRUSES IN THE NEOADJUVANT THERAPY OF CANCER | ROGERS, ERIC JASON | 1638 | §102§103§112 | Non-Final OA | — | Pending | Sep 28, 2021 |
| 17440906 | SYRINGE STERILIZATION VERIFICATION ASSEMBLIES AND METHODS | DIPERT, FORREST BLAKE | 3783 | §103§112 | Non-Final OA | — | Pending | Sep 20, 2021 |
| 17441021 | INJECTOR ACCESSORIES | FARRAR, LAUREN PENG | 3783 | §103 | Final Rejection | — | Pending | Sep 20, 2021 |
| 17436218 | IN VIVO REVERSIBILITY OF HIGH MOLECULAR WEIGHT SPECIES | FRITCHMAN, REBECCA M | 1758 | §101§103 | Non-Final OA | 8d | Pending | Sep 03, 2021 |
| 17419406 | CONTINUOUS DOSING SYSTEMS AND APPROACHES | GOLLAMUDI, NEERAJA | 3783 | §112 | Final Rejection | — | Pending | Jun 29, 2021 |
| 17277533 | PLATFORM ASSEMBLY PROCESS FOR DRUG DELIVERY DEVICE | LALONDE, ALEXANDRA ELIZABETH | 3783 | §103§112 | Final Rejection | 65d | Pending | Mar 18, 2021 |
| 17264139 | INTERVENTIONAL DOSING SYSTEMS AND METHODS | MARRISON, SAMUEL JOSEPH | 3783 | §103 | Non-Final OA | 4d overdue | Pending | Jan 28, 2021 |
| 17036690 | DRUG DELIVERY DEVICE | LALONDE, ALEXANDRA ELIZABETH | 3783 | §102§103 | Non-Final OA | 22d | Pending | Sep 29, 2020 |
| 16898628 | DRUG DELIVERY DEVICE WITH A ROTATABLE DRIVE MECHANISM | RADOMSKI, MARTIN ADAM | 3783 | §103§112 | Non-Final OA | — | Pending | Jun 11, 2020 |
| 16771641 | METHOD OF TREATING IDIOPATHIC THROMBOCYTOPENIA PURPURA (ITP) WITH ROMIPLOSTIM | DABKOWSKI, ERINNE R | 1654 | §102§112 | Non-Final OA | — | Pending | Jun 10, 2020 |
| 16763515 | METHODS FOR PRODUCING PROTEIN PRODUCTS | HURST, JONATHAN M | 1799 | §103 | Final Rejection | 162d overdue | Pending | May 12, 2020 |
| 16869793 | DOSING REGIMEN FOR ANTI-BCMA AGENTS | BRISTOL, LYNN ANNE | 1643 | §112 | Non-Final OA | — | Pending | May 08, 2020 |
| 16348653 | COMBINED THERAPIES FOR ATHEROSCLEROSIS, INCLUDING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE | WEN, SHARON X | 1641 | §103DP | Non-Final OA | — | Pending | May 09, 2019 |
| 13931716 | METHODS FOR TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS | WEN, SHARON X | 1641 | §103DP | Final Rejection | 18d overdue | Pending | Jun 28, 2013 |
| 18704120 | SUBCUTANEOUS ADMINISTRATION OF CD19-BINDING T CELL ENGAGERS | CANELLA, KAREN A | — | §103§112 | Non-Final OA | — | Pending | Apr 24, 2024 |
| 18430415 | BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3 | NATARAJAN, MEERA | — | §112DP | Non-Final OA | — | Pending | Feb 01, 2024 |
| 18556998 | METHODS FOR REDUCING LOW MOLECULAR WEIGHT SPECIES OF RECOMBINANTLY-PRODUCED PROTEINS | SZPERKA, MICHAEL EDWARD | 1641 | §102§103§112 | Non-Final OA | — | Pending | Oct 24, 2023 |
| 18038880 | Mechanistic Ion-Exchange Chromatography Model Calibration | DARRIGRAND, EMILY ANN | 2857 | §101§102§103§112 | Non-Final OA | — | Pending | May 25, 2023 |
| 18038886 | MOLECULES WITH MULTIPLE BINDING DOMAINS | PETERS, ALEC JON | 1641 | §103§112DP | Non-Final OA | — | Pending | May 25, 2023 |
| 18314577 | Single chain binding molecules comprising N-terminal ABP | SKELDING, ZACHARY S | 1644 | DP | Non-Final OA | — | Pending | May 09, 2023 |
| 18251133 | ANTIGEN BINDING DOMAIN WITH REDUCED CLIPPING RATE | BOWLES, DAVID PAUL | 1654 | §102§103DP | Non-Final OA | — | Pending | Apr 28, 2023 |
| 18164304 | TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA | DUFFY, BRADLEY | 1643 | §102§103§112DP | Non-Final OA | — | Pending | Feb 03, 2023 |
| 18066972 | CROSS-SPECIES-SPECIFIC BINDING DOMAIN | DUFFY, BRADLEY | 1643 | §102DP | Non-Final OA | — | Pending | Dec 15, 2022 |
| 17932739 | TREATMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA | HOLTZMAN, KATHERINE ANN | 1646 | §103§112DP | Non-Final OA | — | Pending | Sep 16, 2022 |
| 17775543 | DOSAGE REGIMEN FOR ANTI-EGFRVIII AGENTS | CHASE, CAROL ANN | 1646 | §103§112DP | Non-Final OA | 86d overdue | Pending | May 09, 2022 |
| 17605061 | MEANS AND METHODS FOR TREATING BURKITT LYMPHOMA OR LEUKEMIA | WU, JULIE ZHEN QIN | 1643 | Other | Final Rejection | 43d | Pending | Oct 20, 2021 |
| 17480504 | Means and Methods for Treating Tumorous Diseases | MOSELEY II, NELSON B | 1642 | §103 | Final Rejection | — | Pending | Sep 21, 2021 |
| 16586318 | CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS | SKELDING, ZACHARY S | 1644 | §112 | Non-Final OA | 77d overdue | Pending | Sep 27, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial